WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial

Versatile analog device offers fast inflation and ease of use, streamlining patient care

Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.

New products broaden Merit’s leadership in embolotherapy.

First Patient Enrolled in Merit Medical’s MOTION Study

Merit Medical Announces Process for Chief Executive Officer Succession Planning

New multipurpose microcatheter length complements Merit’s radial-first legacy

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety

Modern design advances patient care by combining hemostasis with innovative cooling capability